Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1016/s1074-7613(01)00145-5
Read article for free, from open access legal sources, via Unpaywall: http://www.cell.com/article/S1074761301001455/pdf
References
Articles referenced by this article (49)
Checkpoints in the progression of autoimmune disease: lessons from diabetes models.
Proc Natl Acad Sci U S A, (6):2260-2263 1996
MED: 8637860
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.
Nature, (6766):211-216 2000
MED: 10646608
Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes.
J Immunol, (5):2677-2682 1999
MED: 10072511
Identification of a putative G protein-coupled receptor induced during activation-induced apoptosis of T cells.
Cell Immunol, (1):78-84 1996
MED: 8599842
Integration of T cell receptor-dependent signaling pathways by adapter proteins.
Annu Rev Immunol, 89-108 1999
MED: 10358754
Chemokines and cell migration in secondary lymphoid organs.
Science, (5447):2098-2102 1999
MED: 10617422
The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation.
Immunity, (5):635-646 1995
MED: 7584153
Show 10 more references (10 of 49)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/s1074-7613(01)00145-5
Article citations
From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling.
Molecules, 29(15):3694, 04 Aug 2024
Cited by: 0 articles | PMID: 39125098 | PMCID: PMC11314389
Review Free full text in Europe PMC
Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms.
Front Immunol, 15:1275203, 08 May 2024
Cited by: 0 articles | PMID: 38779685 | PMCID: PMC11109379
Review Free full text in Europe PMC
Efferocytosis: Current status and future prospects in the treatment of autoimmune diseases.
Heliyon, 10(7):e28399, 31 Mar 2024
Cited by: 1 article | PMID: 38596091 | PMCID: PMC11002059
Review Free full text in Europe PMC
Loss of the mammalian G-protein coupled receptor, G2A, modulates severity of invasive pulmonary aspergillosis.
Front Immunol, 14:1173544, 26 Jun 2023
Cited by: 1 article | PMID: 37435068 | PMCID: PMC10331294
Rural and urban exposures shape early life immune development in South African children with atopic dermatitis and nonallergic children.
Allergy, 79(1):65-79, 03 Aug 2023
Cited by: 3 articles | PMID: 37534631 | PMCID: PMC10952395
Go to all (124) article citations
Other citations
Wikipedia
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity.
Immunity, 15(6):959-970, 01 Dec 2001
Cited by: 101 articles | PMID: 11754817
T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.
Proc Natl Acad Sci U S A, 101(1):245-250, 17 Dec 2003
Cited by: 128 articles | PMID: 14681556 | PMCID: PMC314170
Direct genetic demonstration of G alpha 13 coupling to the orphan G protein-coupled receptor G2A leading to RhoA-dependent actin rearrangement.
Proc Natl Acad Sci U S A, 97(22):12109-12114, 01 Oct 2000
Cited by: 44 articles | PMID: 11050239 | PMCID: PMC17302
T-cell receptor transgenic mice in the study of autoimmune diseases.
J Autoimmun, 22(2):95-106, 01 Mar 2004
Cited by: 9 articles | PMID: 14987736
Review
Mechanisms of autoimmunity in the context of T-cell tolerance: insights from natural and transgenic animal model systems.
Immunol Rev, 118:165-192, 01 Dec 1990
Cited by: 12 articles | PMID: 2150401
Review
Funding
Funders who supported this work.
NCI NIH HHS (2)
Grant ID: CA76204
Grant ID: T32 CA090576